Saturday, July 11, 2026

Drug profile · INN

0.5mg cy150112

0.5mg cy150112 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — 0.5mg cy150112
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

0.5mg cy150112 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN 0.5mg cy150112

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Telavancin Phase 3 · Cumberland Pharmaceuticals · Bacteremia

Frequently asked questions

What is 0.5mg cy150112?

0.5mg cy150112 is an FDA-listed pharmaceutical active ingredient.